Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/14/2010WO2010065787A3 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
10/14/2010WO2010065746A3 Piperazine modulators of nk-1 receptors
10/14/2010WO2010065085A3 Methods and compositions for treating or preventing pruritis
10/14/2010WO2010063011A3 Methods for the treatment of infections and tumors
10/14/2010WO2010062966A3 Methods for inducing mixed chimerism
10/14/2010WO2010059561A3 Systems and methods for treatment of aneurysms using zinc chelator(s)
10/14/2010WO2010059253A9 Methods and compositions for localized agent delivery
10/14/2010WO2010059244A3 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
10/14/2010WO2010057104A3 Pyridoindole modulators of nmda receptor and acetylcholinesterase
10/14/2010WO2010057088A3 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
10/14/2010WO2010056741A3 Phenylacetic acid inhibitors of cyclooxygenase
10/14/2010WO2010056205A9 Intravascular contrast agents
10/14/2010WO2010045369A3 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells
10/14/2010WO2010041218A3 Oxazolidinyl antibiotics
10/14/2010WO2010036399A3 Antiviral drugs for treatment of arenavirus infection
10/14/2010WO2010030781A3 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancer
10/14/2010WO2010020799A3 Compositions for the treatment of neoplastic diseases
10/14/2010WO2010020518A3 Improvements relating to nanodisperse compositions
10/14/2010WO2010009487A8 Chlorophyll catabolites
10/14/2010WO2009151498A3 Memantine formulations
10/14/2010WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
10/14/2010WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof
10/14/2010WO2009124013A8 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/14/2010WO2009120182A3 Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or actives
10/14/2010WO2009114098A8 Methods of treating hyperacidic disorders
10/14/2010WO2009110005A3 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
10/14/2010WO2009109952A3 Detection and treatment of an invasive cancer phenotype
10/14/2010WO2009044019A9 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
10/14/2010WO2009044018A9 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
10/14/2010US20100263066 Inert dna sequences for efficient viral packaging and methods of use
10/14/2010US20100263065 Materials and methods for gene mediated therapy of psychiatric disorders
10/14/2010US20100263062 Methods for screening and compounds that protect against amyloid diseases
10/14/2010US20100262238 Diazeniumdiolated Phosphorylcholine Polymers for Nitric Oxide Release
10/14/2010US20100262120 Method and device for controlling drug pharmacokinetics
10/14/2010US20100262115 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261797 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
10/14/2010US20100261796 Use of Novel Compounds for IBD Treatment
10/14/2010US20100261795 Antiacneic compositions
10/14/2010US20100261793 Method for decreasing cartilage damage in dogs
10/14/2010US20100261791 Compositions and Methods for Improving or Preserving Brain Function
10/14/2010US20100261790 Body-weight maintenance and body composition
10/14/2010US20100261789 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
10/14/2010US20100261788 Inhibition of Bid-Induced Cell-Death Using Small Organic Molecules
10/14/2010US20100261787 Pharmaceutical composition for diabetic nephropathy and its preparation and application
10/14/2010US20100261786 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype
10/14/2010US20100261785 Compositions containing sesamin-class compound(s) and arachidonic acid class compound(s)
10/14/2010US20100261784 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
10/14/2010US20100261783 Cruciferous 3h-1,2-dithiole-3-thione (d3t) and methods of protecting against cell injury
10/14/2010US20100261781 Multivalent aptamer complexes
10/14/2010US20100261780 Highly Acidic Chitosan-Nucleic Acid Polyplex Compositions
10/14/2010US20100261779 Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity
10/14/2010US20100261776 Bruton's tyrosine kinase as anti-cancer drug target
10/14/2010US20100261775 Polymorphic form of duloxetine hydrochloride
10/14/2010US20100261774 Methods for the modulation of Leishmania major infection in mammals
10/14/2010US20100261773 3.3.0 BICYCLIC GlyT1 INHIBITORS AND METHODS OF MAKING AND USING SAME
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261771 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
10/14/2010US20100261770 Pharmaceutical composition for improving lower urinary tract symptoms
10/14/2010US20100261769 Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin
10/14/2010US20100261768 Bioavailable Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide Compound
10/14/2010US20100261767 Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disorders
10/14/2010US20100261766 Phenyl-Oxetanyl-Derivatives
10/14/2010US20100261765 Mineralocorticoid receptor modulators
10/14/2010US20100261764 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
10/14/2010US20100261763 Antibacterial agents and methods of use thereof
10/14/2010US20100261762 Serotonin and norepinephrine reuptake inhibitor
10/14/2010US20100261761 Novel Sulfonylpyrroles
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261759 Substituted oxazolidinones and their use
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261756 method for inhibiting platelet aggregation
10/14/2010US20100261755 Isoxazol-3(2h)-one analogs as therapeutic agents
10/14/2010US20100261754 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
10/14/2010US20100261753 Methods for preventing and/or treating degenerative disorders of the central nervous system
10/14/2010US20100261752 5-ht4 receptor agonist compounds for treatment of cognitive disorders
10/14/2010US20100261751 Method for determining one of the two human immunodeficiency virus (hiv) integrase enzymatic activities
10/14/2010US20100261750 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/14/2010US20100261749 Method of preventing or ameliorating psoriasis using pyrroloquinoline quinone compounds
10/14/2010US20100261748 Stable loratadine spill resistant formulation
10/14/2010US20100261747 Novel pharmaceutical compositions and methods of preparation and use
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261743 Novel seh inhibitors and their use
10/14/2010US20100261742 Novel polymorphic forms
10/14/2010US20100261741 Quinazolinone T-Type Calcium Channel Antagonists
10/14/2010US20100261740 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
10/14/2010US20100261739 Method of Treating Non-Small Cell Lung Cancer
10/14/2010US20100261738 Novel polymorphs of erlotinib hydrochloride and method of preparation
10/14/2010US20100261737 Method of Treating Erectile Dysfunction
10/14/2010US20100261736 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular disease
10/14/2010US20100261734 Methods of Treating Bladder Dysfunction Using Netupitant
10/14/2010US20100261733 Therapeutic agents 927
10/14/2010US20100261732 1, 2, 4 -triazole derivatives as serotonergic modulators
10/14/2010US20100261731 Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate
10/14/2010US20100261730 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/14/2010US20100261729 Methods for the treatment of erectile dysfunction using fispemifene
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
1 ... 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 ... 7860